The effect of the probiotic supplement—ASTARTE™—on the reduction of recurrent urinary tract infection in women aged 18-40 years: protocol for a randomized, double-blind, placebo-controlled study

Key Points

• To investigate the effectiveness of the probiotic supplement Astarte in reducing recurrent urinary tract infections in women aged 18-40.
• Conducted a randomized, double-blind, placebo-controlled trial.
• Involves women aged 18-40 with recurrent urinary tract infections.
• Participants received either Astarte probiotic or a placebo.
• The study aims to identify significant differences in infection rates between the probiotic and placebo groups.
• Expected outcomes include reduced recurrence of infections in the probiotic group.

Abstract